Evidence map›Paper›PMID 20636812›Full record

ReviewImmunological reviews2010

Regulation of CD4+ T-cell contraction during pathogen challenge.

K Kai McKinstry, Tara M Strutt, Susan L Swain

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Immunological reviews, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02681302 phase1 / phase2terminatednot on this mapstarted 2016, after this paper: background citation

Phase Ib-IIA Study of Combined Check Point Inhibition After Autologous Hematopoietic Stem Cell Transplantation in Patients at High Risk for Post-transplant Recurrence

TypeinterventionalSponsorHackensack Meridian HealthRan2016 to 2024Enrolled46ConditionsMultiple Myeloma, LymphomaArmsIpilimumab, Nivolumab
NCT02846376 phase1terminatednot on this mapstarted 2019, after this paper: background citation

Phase I Study of Single-agent and Combined Checkpoint Inhibition After Allogeneic Hematopoietic Stem Cell Transplantation in Patients at High Risk for Post-transplant Recurrence

TypeinterventionalSponsorHackensack Meridian HealthRan2019 to 2023Enrolled8ConditionsAcute Myeloid Leukemia and Myelodysplastic SyndromeArmsNivolumab, Ipilimumab
3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. CD73 Expression by CD4Immunology · 2025
    Article
  3. Review
  4. Immune Aging in Rheumatoid Arthritis.Arthritis & rheumatology (Hoboken, N.J.) · 2025
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.International journal of molecular sciences · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

K Kai McKinstryDepartment of Pathology, University of Massachusetts Medical School, Worcester, MA 01655, USA.
Tara M Strutt
Susan L Swain
University of Massachusetts Chan Medical School · US

Funding

T cell memory to TB in the lungP01AI046530 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 1999 to 2013
$22.2M
Impact of aging on naive CD4 T cell functionR37AG025805 · NIA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2005 to 2014
$3.9M
Histamine Receptor Signaling in CNS Autoimmune DiseaseR01NS061014 · NINDS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI TEUSCHER, CORY · 2008 to 2012
$3.1M
CD4 effector contraction in influenzaR01AI076534 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SWAIN, SUSAN L · 2009 to 2012
$1.7M
NIAID NIH HHS P01 AI046530NIAID NIH HHS P01AI46530NIAID NIH HHS R01 AI076534NIAID NIH HHS R01AI76534NIA NIH HHS R37 AG025805NINDS NIH HHS R01 NS061014PHS HHS RNS061014
6 · The paper itself

Abstract

Signals orchestrating productive CD4+ T-cell responses are well documented; however, the regulation of contraction of CD4+ T-cell effector populations following the resolution of primary immune responses is not well understood. While distinct mechanisms of T-cell death have been defined, the relative importance of discrete death pathways during the termination of immune responses in vivo remains unclear. Here, we review the current understanding of cell-intrinsic and -extrinsic variables that regulate contraction of CD4+ T-cell effector populations through multiple pathways that operate both initially during T-cell priming and later during the effector phase. We discuss the relative importance of antigen-dependent and -independent mechanisms of CD4+ T-cell contraction during in vivo responses, with a special emphasis on influenza virus infection. In this model, we highlight the roles of greater differentiation and presence in the lung of CD4+ effector T cells, as well as their polarization to particular T-helper subsets, in maximizing contraction. We also discuss the role of autocrine interleukin-2 in limiting the extent of contraction, and we point out that these same factors regulate contraction during secondary CD4+ T-cell responses.

Indexed as

ApoptosisCD4-Positive T-LymphocytesHumansInfluenza, HumanInterleukin-2Lymphocyte ActivationModels, ImmunologicalSignal TransductionT-Lymphocytes, Helper-InducerT-Lymphocytes, RegulatoryInterleukin-2

Identifiers

PMID20636812
PMCPMC2908916
OpenAlexW1509274319

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.